Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000094.xml
Download PDF
Z Gastroenterol 2015; 53(11): 1350-1352
DOI: 10.1055/s-0041-103525
DOI: 10.1055/s-0041-103525
Aktuelle Studien
Die INCA-Studie (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): Präzise medizinische Therapie der Patienten mit Leberzirrhose und Aszites
The INCA trial (impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): Precision medicine for patients with liver cirrhosis and ascitesAuthors
Further Information
Publication History
23 June 2015
06 July 2015
Publication Date:
12 November 2015 (online)
-
Literatur
- 1 Appenrodt B, Grünhage F, Gentemann MG et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 2010; 51: 1327-1333
- 2 Karlsen TH, Lammert F, Thompson RJ. Genetics of liver disease: From pathophysiology to clinical practice. J Hepatol 2015; 62: S6-S14
- 3 Jameson JL, Longo DL. Precision medicine – personalized, problematic and promising. N Engl J Med 2015; 372: 229-2234